NCT01893229 Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania Status UNKNOWN Phase PHASE4
NCT01864551 Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder Status COMPLETED Phase PHASE4
NCT01687478 A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression Status TERMINATED Phase PHASE3
NCT01625923 A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis Status TERMINATED Phase NA
NCT01617200 Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689) Status COMPLETED Phase PHASE3
NCT01617187 A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) Status COMPLETED Phase PHASE3
NCT01609153 Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy Status COMPLETED Phase PHASE4
NCT01607762 A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics Status COMPLETED Phase PHASE1
NCT01539733 Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer Status COMPLETED Phase NA
NCT01503424 Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study Status COMPLETED Phase PHASE1
NCT01503398 Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT01498770 An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) Status COMPLETED Phase N/A
NCT01485692 Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation Status COMPLETED Phase NA
NCT01389908 A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder Status UNKNOWN Phase NA
NCT01303601 Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression Status COMPLETED Phase PHASE4
NCT01282632 Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression Status COMPLETED Phase PHASE1/PHASE2
NCT01234779 A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia Status COMPLETED Phase PHASE2